696 related articles for article (PubMed ID: 26010610)
1. Metabolomic fingerprint of heart failure with preserved ejection fraction.
Zordoky BN; Sung MM; Ezekowitz J; Mandal R; Han B; Bjorndahl TC; Bouatra S; Anderson T; Oudit GY; Wishart DS; Dyck JR;
PLoS One; 2015; 10(5):e0124844. PubMed ID: 26010610
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
3. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
[TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.
Hunter WG; Kelly JP; McGarrah RW; Khouri MG; Craig D; Haynes C; Ilkayeva O; Stevens RD; Bain JR; Muehlbauer MJ; Newgard CB; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473038
[TBL] [Abstract][Full Text] [Related]
7. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
[TBL] [Abstract][Full Text] [Related]
8. Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF Trial.
Selvaraj S; Patel S; Sauer AJ; McGarrah RW; Jones P; Kwee LC; Windsor SL; Ilkayeva O; Muehlbauer MJ; Newgard CB; Borlaug BA; Kitzman DW; Shah SJ; Shah SH; Kosiborod MN;
JACC Heart Fail; 2024 Jun; 12(6):999-1011. PubMed ID: 38639697
[TBL] [Abstract][Full Text] [Related]
9. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B
J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction.
Wong LL; Armugam A; Sepramaniam S; Karolina DS; Lim KY; Lim JY; Chong JP; Ng JY; Chen YT; Chan MM; Chen Z; Yeo PS; Ng TP; Ling LH; Sim D; Leong KT; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lam CS; Jeyaseelan K; Richards AM
Eur J Heart Fail; 2015 Apr; 17(4):393-404. PubMed ID: 25619197
[TBL] [Abstract][Full Text] [Related]
12. HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin.
Faxén UL; Hage C; Andreasson A; Donal E; Daubert JC; Linde C; Brismar K; Lund LH
Int J Cardiol; 2017 Feb; 228():709-716. PubMed ID: 27886615
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure.
Watson CJ; Gupta SK; O'Connell E; Thum S; Glezeva N; Fendrich J; Gallagher J; Ledwidge M; Grote-Levi L; McDonald K; Thum T
Eur J Heart Fail; 2015 Apr; 17(4):405-15. PubMed ID: 25739750
[TBL] [Abstract][Full Text] [Related]
15. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
Tromp J; Westenbrink BD; Ouwerkerk W; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Lang CC; Ng LL; Zannad F; Zwinderman AH; Hillege HL; van der Meer P; Voors AA
J Am Coll Cardiol; 2018 Sep; 72(10):1081-1090. PubMed ID: 30165978
[TBL] [Abstract][Full Text] [Related]
16. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
Scherbakov N; Bauer M; Sandek A; Szabó T; Töpper A; Jankowska EA; Springer J; von Haehling S; Anker SD; Lainscak M; Engeli S; Düngen HD; Doehner W
Eur J Heart Fail; 2015 Oct; 17(10):1015-21. PubMed ID: 26198713
[TBL] [Abstract][Full Text] [Related]
18. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
[TBL] [Abstract][Full Text] [Related]
19. Left atrial dysfunction relates to symptom onset in patients with heart failure and preserved left ventricular ejection fraction.
Sanchis L; Gabrielli L; Andrea R; Falces C; Duchateau N; Perez-Villa F; Bijnens B; Sitges M
Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):62-7. PubMed ID: 25187609
[TBL] [Abstract][Full Text] [Related]
20. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction.
Kato N; Kinugawa K; Shiga T; Hatano M; Takeda N; Imai Y; Watanabe M; Yao A; Hirata Y; Kazuma K; Nagai R
J Cardiol; 2012 Jul; 60(1):23-30. PubMed ID: 22445598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]